NCT06710626
Control of Assistive Devices Via Brain-Computer Interface Technology
Enrolling by Invitation
NAAll AgesInterventionalNeuralink Corp
~3 participants
Updated 2025-06-05 on ClinicalTrials.gov
What's tested:Assistive Robotic Arm
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant.
Measured over 3-months following first use of the assistive device
Conditions
NCT06710626
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Barrow Neurological Institute
Phoenix, Arizonano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Continued enrollment in the PRIME Study.
Implanted with the N1 Implant.
Exclusion
Explantation or deactivation of the N1 Implant.
Insufficient N1 Implant BCI performance demonstrated.
Lack of a suitable physical space to perform research sessions.
Any condition which, in the opinion of the Investigator, would compromise the candidate's ability to safely participate in the study.
What this trial measures
- Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant.3-months following first use of the assistive device